Suchergebnisse - "9NDF7JZ4M3"

PubPharm (1.537)

1

Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers

enthalten in: Clinical pharmacokinetics | 2024

von Rohr, B. | Krohmer, E. | Foerster, K. | +5

2

The Effect of Levetiracetam Compared with Enzyme-Inducing Antiseizure Medications on Apixaban and Rivaroxaban Peak Plasma Concentrations

enthalten in: CNS drugs | 2024

von Goldstein, R. | Rabkin, N. | Buchman, N. | +7

3

Exploring the effects of Factor Xa inhibitors on thrombin generation in people with haemophilia

enthalten in: Thrombosis research | 2024

von Dix, C. | McFadyen, J. | Tran, H.

4

Comparative effectiveness of factor Xa non-vitamin K antagonist oral anticoagulants versus phenprocoumon in patients with non-valvular atrial fibrillation

enthalten in: International journal of cardiology | 2024

von Kreutz, R. | Kloss, S. | Enders, D. | +4

5

Effectiveness and safety of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease : A multinational cohort study

enthalten in: Thrombosis research | 2024

von Douros, A. | Cui, Y. | Platt, R. | +3

6

Age-related variation in coagulation factors in non-valvular atrial fibrillation patients receiving direct oral anticoagulants

enthalten in: International journal of hematology | 2024

von Kumano, O. | Suzuki, S. | Yamazaki, M. | +28

7

Real-world experience of direct oral anticoagulant use in a single pediatric center

enthalten in: Pediatric blood & cancer | 2024

von Valenti, G. | Sabo, C. | Hyde, M. | +1

8

Clot time ratio (CTR) and treatment outcomes in Apixaban-treated atrial fibrillation patients

enthalten in: Scientific reports | 2024

von Onelöv, L. | Božič-Mijovski, M. | Mavri, A.

9

Risk of Major Bleeding Associated with Concomitant Direct-Acting Oral Anticoagulant and Clopidogrel Use : A Retrospective Cohort Study

enthalten in: Drug safety | 2024

von Hwang, Y. | Chang, H. | Metkus, T. | +4

10

Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis

enthalten in: The European journal of health economics : HEPAC : health economics in prevention and care | 2024

von Situ, M. | Schwarz, U. | Zou, G. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[154]